fintols

Pfizer vs Thermo Fisher (PFE vs TMO)

Pfizer (PFE) vs Thermo Fisher (TMO) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.

Pfizer (PFE) and Thermo Fisher (TMO) compete in healthcare and pharma. Here are Pfizer and Thermo Fisher side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy Pfizer or Thermo Fisher.

Pfizer vs Thermo Fisher: the figures

FigurePfizerThermo Fisher
Share price$30.79 (November 4, 2026)$706.16 (November 4, 2026)
Market cap$175.5 billion$261.6 billion
P/E (TTM)44.0x37.2x
Forward P/E10.6x25.4x
Revenue growth (quarter)-0.4%+9.1%
Net margin (TTM)6.3%14.9%
Net debt / EBITDAN/A2.9x
Dividend yield5.73%0.27%
BetaN/A0.84

Pfizer and Thermo Fisher figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that Pfizer or Thermo Fisher figure is not available, and we never estimate it.

3 key differences between Pfizer and Thermo Fisher

  1. Dividend: Pfizer yields 5.73% at today's price and Thermo Fisher yields 0.27%.
  2. Profitability: for every 100 of sales, Thermo Fisher keeps 14.9 as net profit and Pfizer keeps 6.3.
  3. Growth: Thermo Fisher grew sales +9.1% year on year in its latest quarter, against -0.4% for Pfizer.

Pfizer or Thermo Fisher: which fits your profile

Neither Pfizer nor Thermo Fisher wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.

How Pfizer and Thermo Fisher make money

Pfizer (PFE)

Pfizer sells medicines and vaccines grouped into Primary Care, which includes the blood thinner Eliquis shared with Bristol Myers, Prevnar and Comirnaty vaccines and the antiviral Paxlovid; Specialty Care, led by Vyndaqel; and Oncology, with Ibrance, Xtandi and Seagen drugs like Padcev. The U.S. is its biggest market. Full Pfizer analysis.

Thermo Fisher (TMO)

Thermo Fisher Scientific sells instruments, reagents and services to drugmakers, labs and hospitals. It reports Laboratory Products and Biopharma Services, the largest, including Fisher Scientific distribution, PPD clinical research and contract drug manufacturing; Life Science Solutions; Analytical Instruments; and Specialty Diagnostics. North America is its biggest market. Full Thermo Fisher analysis.

Frequently asked questions: Pfizer vs Thermo Fisher

Is Pfizer or Thermo Fisher the better stock?

Choosing between Pfizer and Thermo Fisher depends on what you are looking for. Thermo Fisher is growing faster right now, and Thermo Fisher trades on the lower P/E. Fintols does not tell you whether to buy Pfizer or Thermo Fisher: it shows you the differences so you can decide.

Which pays a higher dividend, Pfizer or Thermo Fisher?

As of November 4, 2026, Pfizer yields 5.73% and Thermo Fisher yields 0.27%. Also check how much of their profit Pfizer and Thermo Fisher pay out: if it is more than they earn, it cannot last.

Which is more expensive, Pfizer or Thermo Fisher?

On P/E, Pfizer (44.0x) is more expensive than Thermo Fisher (37.2x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.

Can I own both Pfizer and Thermo Fisher?

Yes. Many people spread their money across several companies, such as Pfizer and Thermo Fisher, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying Pfizer or Thermo Fisher.

More comparisons with Pfizer or Thermo Fisher

More companies like Pfizer and Thermo Fisher: healthcare and pharma stocks. Educational content about Pfizer and Thermo Fisher, not investment advice.